Tech Company Financing Transactions

Cytek Biosciences Funding Round

3E Bioventures, Northern Light Venture Capital and private investors invested in a Series C funding round for Cytek Biosciences. The funding round closed on 9/26/2018.

Transaction Overview

Company Name
Cytek Biosciences
Announced On
9/26/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors

3E Bioventures (Lead Investor) (Francine Fang)

Northern Light Venture Capital (Lead Investor) (Feng Deng)

Proceeds Purpose
The funding will be used to facilitate the expansion of Cytek's footprint around the world, as well as to ramp up sales, marketing, operations, and global product offerings.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
46107 Landing Pkwy.
Fremont, CA 94538
USA
Phone
877-922-9835
Website
www.cytekbio.com
Email Address
[email protected]
Overview
Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek's compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world.
Profile
Cytek Biosciences LinkedIn Company Profile
Social Media
Cytek Biosciences Company Twitter Account
Company News
Cytek Biosciences News
Facebook
Cytek Biosciences on Facebook
YouTube
Cytek Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Wenbin Jiang
  Wenbin Jiang LinkedIn Profile  Wenbin Jiang Twitter Account  Wenbin Jiang News  Wenbin Jiang on Facebook
Chief Financial Officer
Patrik Jeanmonod
  Patrik Jeanmonod LinkedIn Profile  Patrik Jeanmonod Twitter Account  Patrik Jeanmonod News  Patrik Jeanmonod on Facebook
Chief Technical Officer
Ming Yan
  Ming Yan LinkedIn Profile  Ming Yan Twitter Account  Ming Yan News  Ming Yan on Facebook
General Manager
Ken Riley
  Ken Riley LinkedIn Profile  Ken Riley Twitter Account  Ken Riley News  Ken Riley on Facebook
VP - Marketing
Mark Herberger
  Mark Herberger LinkedIn Profile  Mark Herberger Twitter Account  Mark Herberger News  Mark Herberger on Facebook
VP - Marketing
Gil Reinin
  Gil Reinin LinkedIn Profile  Gil Reinin Twitter Account  Gil Reinin News  Gil Reinin on Facebook
VP - Sales
Ray Lannigan
  Ray Lannigan LinkedIn Profile  Ray Lannigan Twitter Account  Ray Lannigan News  Ray Lannigan on Facebook
VP - Sales
Steve Ziganti
  Steve Ziganti LinkedIn Profile  Steve Ziganti Twitter Account  Steve Ziganti News  Steve Ziganti on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/26/2018: Bleximo venture capital transaction
Next: 9/26/2018: Cybrary venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.